Ramezan Ali Naeimi1, Fereshteh Talebpour Amiri2, Ali Reza Khalatbary3, Arash Ghasemi4, Mehryar Zargari5, Maryam Ghesemi6, Seyed Jalal Hosseinimehr7. 1. Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran; Department of Anatomy, Faculty of Medicine, Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran. 2. Department of Anatomy, Faculty of Medicine, Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran. Electronic address: ftaleb2001@yahoo.co.uk. 3. Department of Anatomy, Faculty of Medicine, Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran. 4. Department of Radiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. 5. Department of Clinical Biochemistry, Molecular and Cell Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. 6. Pathology Department, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. 7. Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Abstract
BACKGROUND: Radiotherapy in patients with pelvis malignancy causes testes irradiation and resulted in testicular damages. Atorvastatin (ATV) in the low-dose is considered as antioxidant and anti-inflammatory properties. OBJECTIVE: This experimental study was investigated protective effects of ATV on irradiation-induced testicular injury. MATERIAL AND METHODS: Sixty male balb/c mice were randomly divided into 6 groups: 1: control, 2: irradiated (IR), 3, 4 and 5: IR plus ATV (10, 20 and 50mg/kg), 6: only ATV (50mg/kg). The ATV treated groups were received ATV for 7days via oral gavage before IR. Irradiated groups exposed to 2Gy whole body X-ray on day 8. Biochemical, histological and immunohistological parameters were evaluated for radioprotective effect of ATV. RESULTS: In the ATV pretreatment in irradiated mice, MDA levels were significantly decreased compared with the IR group. The effect of all three doses of ATV caused reduced MDA level, but ATV to dose of 50mg/kg had more effect than other doses of ATV. Significant decrease in the concentration of testosterone was observed in only irradiated mice compared with the ATV plus irradiated. In addition, the histological examination showed Johnsen Score in the IR group was lower compared to ATV pretreated groups. ATV significantly reduced caspase-3 immunoreactivity induced by irradiation. CONCLUSION: The results from this study suggest that ATV at low dose has a protective effect against irradiation-induced testicular damage. This result provides a new indication of ATV for protection of testis during radiation therapy in treatment of cancer patients.
BACKGROUND: Radiotherapy in patients with pelvis malignancy causes testes irradiation and resulted in testicular damages. Atorvastatin (ATV) in the low-dose is considered as antioxidant and anti-inflammatory properties. OBJECTIVE: This experimental study was investigated protective effects of ATV on irradiation-induced testicular injury. MATERIAL AND METHODS: Sixty male balb/c mice were randomly divided into 6 groups: 1: control, 2: irradiated (IR), 3, 4 and 5: IR plus ATV (10, 20 and 50mg/kg), 6: only ATV (50mg/kg). The ATV treated groups were received ATV for 7days via oral gavage before IR. Irradiated groups exposed to 2Gy whole body X-ray on day 8. Biochemical, histological and immunohistological parameters were evaluated for radioprotective effect of ATV. RESULTS: In the ATV pretreatment in irradiated mice, MDA levels were significantly decreased compared with the IR group. The effect of all three doses of ATV caused reduced MDA level, but ATV to dose of 50mg/kg had more effect than other doses of ATV. Significant decrease in the concentration of testosterone was observed in only irradiated mice compared with the ATV plus irradiated. In addition, the histological examination showed Johnsen Score in the IR group was lower compared to ATV pretreated groups. ATV significantly reduced caspase-3 immunoreactivity induced by irradiation. CONCLUSION: The results from this study suggest that ATV at low dose has a protective effect against irradiation-induced testicular damage. This result provides a new indication of ATV for protection of testis during radiation therapy in treatment of cancerpatients.
Authors: Tyler A Smith; Daniel R Kirkpatrick; Sean Smith; Trevor K Smith; Tate Pearson; Aparna Kailasam; Kortney Z Herrmann; Johanna Schubert; Devendra K Agrawal Journal: J Transl Med Date: 2017-11-09 Impact factor: 5.531
Authors: Alexander M Aliper; Marine E Bozdaganyan; Viktoria A Sarkisova; Alexander P Veviorsky; Ivan V Ozerov; Philipp S Orekhov; Mikhail B Korzinkin; Alexey Moskalev; Alex Zhavoronkov; Andreyan N Osipov Journal: Aging (Albany NY) Date: 2020-08-15 Impact factor: 5.682
Authors: Giulia Rossi; Martina Placidi; Chiara Castellini; Francesco Rea; Settimio D'Andrea; Gonzalo Luis Alonso; Giovanni Luca Gravina; Carla Tatone; Giovanna Di Emidio; Anna Maria D'Alessandro Journal: Molecules Date: 2021-03-17 Impact factor: 4.411